SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950135-05-003297
Filing Date
2005-06-14
Accepted
2005-06-14 14:43:49
Documents
6
Effectiveness Date
2005-06-14

Document Format Files

Seq Description Document Type Size
1 ACCESS PHARMACEUTICALS FORM S-8 b55431apsv8.htm S-8 61349
2 EX-4.5 FORM OF 2005 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT b55431apexv4w5.htm EX-4.5 21889
3 EX-4.6 FORM OF 2005 EQUITY INCENTIVE PLAN RESTRICTED STOCK GRANT AGREEMENT b55431apexv4w6.htm EX-4.6 26037
4 EX-4.7 FORM OF 1995 STOCK AWARDS GRANT b55431apexv4w7.htm EX-4.7 7920
5 EX-5 OPINION OF BINGHAM MCCUTCHEN LLP b55431apexv5.htm EX-5 5787
6 EX-23.1 CONSENT OF GRANT THORNTON LLP b55431apexv23w1.htm EX-23.1 1357
  Complete submission text file 0000950135-05-003297.txt   125950
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-125796 | Film No.: 05894559
SIC: 2834 Pharmaceutical Preparations